These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38682226)

  • 1. Neuromyelitis Optica Spectrum Disorder in Latin America: State-of-the-Art and Current Challenges.
    Carnero Contentti E; Eizaguirre B; López PA; Silva B; Tkachuk VA; Tizio S; Alonso R
    J Integr Neurosci; 2024 Apr; 23(4):74. PubMed ID: 38682226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status of the neuromyelitis optica spectrum disorder in Latin America.
    Rivera VM; Hamuy F; Rivas V; Gracia F; Rojas JI; Bichuetti DB; Villa AM; Marques VD; Soto A; Bertado B; Frenk IT; Galleguillos L; Quiñones J; Ramirez DA; Caparó-Zamalloa C; Ciampi E; Lana-Peixoto MA; Rodríguez E; Zarco L; Sinay V; Armas E; Becker J; Benzadón A; Lopez E; Carnero Contentti E; Correa-Diaz EP; Diaz A; Fleitas CV; Playas G; Molina O; Rojas E; Sato D; Soto I; Céspedes JV; Correale J; Barboza A; Monterrey P; Candelario A; Tavolini DR; Parajeles A; Pujol BS; Diaz de la Fe A; Alonso R; Bolaña C; Guzman MK; Carrá A; Gamarra OG; Raggio JV; Rodriguez LC; Ramirez NE; Ordoñez L; Skromne E; Portillo LL; Canabal AP; Weiser R; Sirias V; Calderón RF; Cornejo EA; Hernández M; Quiroz JCD; Garcia LA; Cedeño CO; Martínez J; Abad-Herrera P
    Mult Scler Relat Disord; 2021 Aug; 53():103083. PubMed ID: 34171682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and paraclinical profile of neuromyelitis optic spectrum disorder in a peruvian cohort.
    Castro-Suarez S; Guevara-Silva E; Osorio-Marcatinco V; Alvarez-Toledo K; Meza-Vega M; Caparó-Zamalloa C
    Mult Scler Relat Disord; 2022 Aug; 64():103919. PubMed ID: 35691236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort.
    Edgar Patricio CD; Eleanor THG; Francisco José CZ; Gabriela ACM; Hyland AO; Fernando GL; María TA; Beatriz N; Marcos SD; Alfredo GPW
    Mult Scler Relat Disord; 2020 Sep; 44():102208. PubMed ID: 32562910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the long-term treatment of neuromyelitis optica spectrum disorder.
    Anderson M; Levy M
    J Cent Nerv Syst Dis; 2024; 16():11795735241231094. PubMed ID: 38312734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study.
    Ibis SC; Omaira M; Arnoldo S; Elizabeth A; Sandra M; Carlota CM; Elizabeth C; Laura V; Rosalba L; Oscar V; Luisa DM; Nahir A; Hernandez F
    Mult Scler Relat Disord; 2021 Jan; 47():102652. PubMed ID: 33279797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis Optica spectrum disorders in Argentina: A hospital-based study.
    Villa AM; Manin A; Seimandi C; Finkelsteyn AM; Ramos G; Tenembaum S
    Mult Scler Relat Disord; 2023 Nov; 79():105018. PubMed ID: 37806234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute optic nerve lesions in first-ever NMOSD-related optic neuritis using conventional brain MRI: A Latin American multicenter study.
    Carnero Contentti E; Delgado-García G; López PA; Criniti J; Pettinicchi JP; Correa-Díaz EP; Soto de Castillo I; Daccach Marques V; Tkachuk V; Cristiano E; Serva Braga Diéguez G; Dos Santos AC; Castillo MC; Patrucco L; Álvarez Pucha MO; Miño Zambrano JE; Gómez-Figueroa E; Rivas-Alonso V; Flores-Rivera J; Caride A; Rojas JI
    Mult Scler Relat Disord; 2020 Nov; 46():102558. PubMed ID: 33032052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice.
    Carnero Contentti E; Rojas JI; Cristiano E; Marques VD; Flores-Rivera J; Lana-Peixoto M; Navas C; Papais-Alvarenga R; Sato DK; Soto de Castillo I; Correale J
    Mult Scler Relat Disord; 2020 Oct; 45():102428. PubMed ID: 32763842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of neuromyelitis optica spectrum disorders - An update.
    Bruscolini A; Sacchetti M; La Cava M; Gharbiya M; Ralli M; Lambiase A; De Virgilio A; Greco A
    Autoimmun Rev; 2018 Mar; 17(3):195-200. PubMed ID: 29339316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients.
    Lana-Peixoto MA; Talim NC; Callegaro D; Marques VD; Damasceno A; Becker J; Gonçalves MVM; Sato H;
    Mult Scler Relat Disord; 2023 Jul; 75():104730. PubMed ID: 37156036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
    Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
    J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica spectrum disorder in Western Mexico.
    Mireles-Ramírez MA; Cortes-Enríquez F; Valdivia-Tangarife ER; Sanchez-Rosales NA; Hernandez-Preciado MR; Gonzalez-Rodriguez CH; García-Rivera JJ; Macias-Islas MA
    Mult Scler Relat Disord; 2022 May; 61():103733. PubMed ID: 35339743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort.
    Carnero Contentti E; Daccach Marques V; Soto de Castillo I; Tkachuk V; Ariel B; Castillo MC; Cristiano E; Diégues Serva GB; Dos Santos AC; Finkelsteyn AM; López PA; Patrucco L; Molina O; Pettinicchi JP; Toneguzzo V; Caride A; Rojas JI
    J Neurol; 2020 May; 267(5):1260-1268. PubMed ID: 31932911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunobiology of neuromyelitis optica spectrum disorders.
    Mora Cuervo DL; Hansel G; Sato DK
    Curr Opin Neurobiol; 2022 Oct; 76():102618. PubMed ID: 35973380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive review of the advances in neuromyelitis optica spectrum disorder.
    Siriratnam P; Huda S; Butzkueven H; van der Walt A; Jokubaitis V; Monif M
    Autoimmun Rev; 2023 Dec; 22(12):103465. PubMed ID: 37852514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of neuromyelitis optica spectrum disorders in childhood].
    Zhou J; Zhang Y; Ji TY; Jin YW; Bao XH; Zhang YH; Xiong H; Chang XZ; Jiang YW; Wu Y
    Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):118-124. PubMed ID: 30695886
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple sclerosis and neuromyelitis optica spectrum disorder testing and treatment availability in Latin America.
    Rojas JI; Gracia F; Patrucco L; Alonso R; Carnero Contentti E; Cristiano E
    Neurol Res; 2021 Dec; 43(12):1081-1086. PubMed ID: 34240685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.